0
0
scientific publications
0
0
innovation projects: Cardiopulmonary, In-silico, Fibrosis and Oncology
0
0
Banook Award presented since the launch of the Center of Excellence
Why the Center of Excellence?
Shaping the future of digital biomarkers through science, collaboration and innovation
The Banook Center of Excellence (CoE) brings together our internal innovation team with leading stakeholders from industry and academia to shape the future of digital biomarkers in drug development. By pooling expertise across clinical science, data science, and regulatory affairs, the CoE creates a shared space where emerging ideas are stress-tested against real-world development challenges before they reach the market.
Our core mission is to anticipate what the market needs, now and over the next several years. Through structured collaboration with pharmaceutical sponsors, technology partners, and academic researchers, the CoE identifies where digital biomarkers can meaningfully accelerate timelines and reduce risk across the drug development lifecycle, from early discovery through late-stage trials.
What We Do
Driving innovation from scientific discovery to regulatory adoption
We bring together pharmaceutical sponsors, technology partners and academic researchers to address today's challenges and anticipate tomorrow's opportunities in digital biomarkers
By identifying emerging scientific and clinical needs, we help define Banook's innovation priorities and guide the development of future solutions
We contribute to the scientific community through peer-reviewed publications, webinars and educational content, promoting transparency and the adoption of digital biomarkers
Working alongside regulatory authorities, including the FDA and EMA, we support biomarker qualification and help transform scientific advances into trusted clinical solutions
Projects are evaluated based on four key principles: scientific excellence, clinical relevance, regulatory readiness and patient impact.
We primarily focus on initiatives aligned with Banook’s core areas of expertise, including:
Cardiopulmonary diseases,
Fibrosis,
Oncology,
and In-Silico trials
Our Approach
Every initiative is driven by scientific rigor, clinical relevance and long-term impact
The Center of Excellence focuses on initiatives with the greatest potential to advance digital biomarkers and improve clinical research. Every project is assessed through a multidisciplinary lens, ensuring that scientific innovation is matched by clinical applicability, regulatory feasibility and meaningful value for patients and sponsors. By combining expertise across multiple disciplines, we prioritize ideas that can generate robust evidence and support the future adoption of digital biomarkers in drug development.
Scientific Excellence: Projects are built on robust scientific evidence and methodological rigor
Clinical Relevance: Every initiative must address a genuine clinical need and improve decision-making
Regulatory Readiness: Innovation is developed with future regulatory acceptance in mind
Collaborative Impact: We prioritize projects that benefit from multidisciplinary expertise and strategic partnerships
Patient Benefit: The ultimate objective is to improve clinical research and patient outcomes
Banook Award
Celebrating innovation in clinical research
Created as an initiative of the Banook Center of Excellence, The Banook Award recognizes outstanding scientific initiatives that have the potential to advance clinical research and improve patient care. By celebrating innovative ideas aligned with the Center of Excellence mission, the award encourages collaboration between academia, industry, and healthcare professionals while supporting the development of the next generation of digital biomarkers and clinical endpoint solutions.
Join the Innovation
Together, we can turn scientific innovation into clinical impact
Whether you are a pharmaceutical innovator, technology developer, or academic researcher, the Banook Center of Excellence offers a proven platform to collaborate, publish, and help set the standard for digital biomarkers in drug development.
